Symptoms associated with long-term benzodiazepine use in elderly individuals aged 65 years and older: A longitudinal descriptive study

Sari Vaapio, Juha Puustinen, Marika J. Salminen, Tero Vahlberg, Maritta Salonoja, Alan Lyles, Sirkka Liisa Kivelä

Research output: Contribution to journalArticle

Abstract

Summary Background Recent epidemiologic studies have shown that the use of psychotropics is associated with many symptoms and may result in dependence and tolerance among elderly individuals. The aim of this study was to describe the symptoms related to withdrawal or dose reduction of long-term benzodiazepine (BZD) or BZD-related drugs (RDs) use and to compare them with nonuse of these drugs in community-dwelling individuals aged 65 and older. Methods The study was a post hoc analysis embedded in a 12-month randomized, controlled fall-prevention trial that included withdrawal of BZDs and RDs. The participants (n = 248) in the intervention group were divided into the following four groups according to their use of BZDs/RDs at baseline and follow-up: (1) withdrawal (WG), (2) reduction (RG), (3) unchanged (UG), and (4) nonusers (NUG). Differences in symptom changes were compared between and within these four groups. Results Using BZD/RD was associated with numerous symptoms at baseline and during the intervention. At follow-up, those symptoms reduced significantly among all participants. However, there were no significant differences between the groups in the changes of symptoms during the follow-up. Self-perceived health improved in only NUG (p <0.001), but not in the other groups (WG, RG, and UG). Conclusion Withdrawal or reduction of BZD/RD produced positive effects on physical, psychological, or cognitive symptoms among all participants, but no differences between the groups were detected. We recommend that clinical goals should be carefully assessed against the risks of long-term BZD/RD use, and that withdrawal interventions should be initiated for community-dwelling users aged 65 and older, especially those long-term users who may already be experiencing adverse drug effects.

Original languageEnglish (US)
Article number272
Pages (from-to)34-39
Number of pages6
JournalInternational Journal of Gerontology
Volume9
Issue number1
DOIs
StatePublished - Mar 1 2015
Externally publishedYes

Fingerprint

Benzodiazepines
Longitudinal Studies
Pharmaceutical Preparations
Independent Living
Neurobehavioral Manifestations
Epidemiologic Studies
Psychology
Health

Keywords

  • aged
  • psychotropics
  • reduction
  • symptoms
  • withdrawal

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Symptoms associated with long-term benzodiazepine use in elderly individuals aged 65 years and older : A longitudinal descriptive study. / Vaapio, Sari; Puustinen, Juha; Salminen, Marika J.; Vahlberg, Tero; Salonoja, Maritta; Lyles, Alan; Kivelä, Sirkka Liisa.

In: International Journal of Gerontology, Vol. 9, No. 1, 272, 01.03.2015, p. 34-39.

Research output: Contribution to journalArticle

Vaapio, Sari ; Puustinen, Juha ; Salminen, Marika J. ; Vahlberg, Tero ; Salonoja, Maritta ; Lyles, Alan ; Kivelä, Sirkka Liisa. / Symptoms associated with long-term benzodiazepine use in elderly individuals aged 65 years and older : A longitudinal descriptive study. In: International Journal of Gerontology. 2015 ; Vol. 9, No. 1. pp. 34-39.
@article{b2ec5aa2cdd5495f891ffc03ac6a43fc,
title = "Symptoms associated with long-term benzodiazepine use in elderly individuals aged 65 years and older: A longitudinal descriptive study",
abstract = "Summary Background Recent epidemiologic studies have shown that the use of psychotropics is associated with many symptoms and may result in dependence and tolerance among elderly individuals. The aim of this study was to describe the symptoms related to withdrawal or dose reduction of long-term benzodiazepine (BZD) or BZD-related drugs (RDs) use and to compare them with nonuse of these drugs in community-dwelling individuals aged 65 and older. Methods The study was a post hoc analysis embedded in a 12-month randomized, controlled fall-prevention trial that included withdrawal of BZDs and RDs. The participants (n = 248) in the intervention group were divided into the following four groups according to their use of BZDs/RDs at baseline and follow-up: (1) withdrawal (WG), (2) reduction (RG), (3) unchanged (UG), and (4) nonusers (NUG). Differences in symptom changes were compared between and within these four groups. Results Using BZD/RD was associated with numerous symptoms at baseline and during the intervention. At follow-up, those symptoms reduced significantly among all participants. However, there were no significant differences between the groups in the changes of symptoms during the follow-up. Self-perceived health improved in only NUG (p <0.001), but not in the other groups (WG, RG, and UG). Conclusion Withdrawal or reduction of BZD/RD produced positive effects on physical, psychological, or cognitive symptoms among all participants, but no differences between the groups were detected. We recommend that clinical goals should be carefully assessed against the risks of long-term BZD/RD use, and that withdrawal interventions should be initiated for community-dwelling users aged 65 and older, especially those long-term users who may already be experiencing adverse drug effects.",
keywords = "aged, psychotropics, reduction, symptoms, withdrawal",
author = "Sari Vaapio and Juha Puustinen and Salminen, {Marika J.} and Tero Vahlberg and Maritta Salonoja and Alan Lyles and Kivel{\"a}, {Sirkka Liisa}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.ijge.2014.03.009",
language = "English (US)",
volume = "9",
pages = "34--39",
journal = "International Journal of Gerontology",
issn = "1873-9598",
publisher = "Elsevier Taiwan LLC",
number = "1",

}

TY - JOUR

T1 - Symptoms associated with long-term benzodiazepine use in elderly individuals aged 65 years and older

T2 - A longitudinal descriptive study

AU - Vaapio, Sari

AU - Puustinen, Juha

AU - Salminen, Marika J.

AU - Vahlberg, Tero

AU - Salonoja, Maritta

AU - Lyles, Alan

AU - Kivelä, Sirkka Liisa

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Summary Background Recent epidemiologic studies have shown that the use of psychotropics is associated with many symptoms and may result in dependence and tolerance among elderly individuals. The aim of this study was to describe the symptoms related to withdrawal or dose reduction of long-term benzodiazepine (BZD) or BZD-related drugs (RDs) use and to compare them with nonuse of these drugs in community-dwelling individuals aged 65 and older. Methods The study was a post hoc analysis embedded in a 12-month randomized, controlled fall-prevention trial that included withdrawal of BZDs and RDs. The participants (n = 248) in the intervention group were divided into the following four groups according to their use of BZDs/RDs at baseline and follow-up: (1) withdrawal (WG), (2) reduction (RG), (3) unchanged (UG), and (4) nonusers (NUG). Differences in symptom changes were compared between and within these four groups. Results Using BZD/RD was associated with numerous symptoms at baseline and during the intervention. At follow-up, those symptoms reduced significantly among all participants. However, there were no significant differences between the groups in the changes of symptoms during the follow-up. Self-perceived health improved in only NUG (p <0.001), but not in the other groups (WG, RG, and UG). Conclusion Withdrawal or reduction of BZD/RD produced positive effects on physical, psychological, or cognitive symptoms among all participants, but no differences between the groups were detected. We recommend that clinical goals should be carefully assessed against the risks of long-term BZD/RD use, and that withdrawal interventions should be initiated for community-dwelling users aged 65 and older, especially those long-term users who may already be experiencing adverse drug effects.

AB - Summary Background Recent epidemiologic studies have shown that the use of psychotropics is associated with many symptoms and may result in dependence and tolerance among elderly individuals. The aim of this study was to describe the symptoms related to withdrawal or dose reduction of long-term benzodiazepine (BZD) or BZD-related drugs (RDs) use and to compare them with nonuse of these drugs in community-dwelling individuals aged 65 and older. Methods The study was a post hoc analysis embedded in a 12-month randomized, controlled fall-prevention trial that included withdrawal of BZDs and RDs. The participants (n = 248) in the intervention group were divided into the following four groups according to their use of BZDs/RDs at baseline and follow-up: (1) withdrawal (WG), (2) reduction (RG), (3) unchanged (UG), and (4) nonusers (NUG). Differences in symptom changes were compared between and within these four groups. Results Using BZD/RD was associated with numerous symptoms at baseline and during the intervention. At follow-up, those symptoms reduced significantly among all participants. However, there were no significant differences between the groups in the changes of symptoms during the follow-up. Self-perceived health improved in only NUG (p <0.001), but not in the other groups (WG, RG, and UG). Conclusion Withdrawal or reduction of BZD/RD produced positive effects on physical, psychological, or cognitive symptoms among all participants, but no differences between the groups were detected. We recommend that clinical goals should be carefully assessed against the risks of long-term BZD/RD use, and that withdrawal interventions should be initiated for community-dwelling users aged 65 and older, especially those long-term users who may already be experiencing adverse drug effects.

KW - aged

KW - psychotropics

KW - reduction

KW - symptoms

KW - withdrawal

UR - http://www.scopus.com/inward/record.url?scp=84928203775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928203775&partnerID=8YFLogxK

U2 - 10.1016/j.ijge.2014.03.009

DO - 10.1016/j.ijge.2014.03.009

M3 - Article

AN - SCOPUS:84928203775

VL - 9

SP - 34

EP - 39

JO - International Journal of Gerontology

JF - International Journal of Gerontology

SN - 1873-9598

IS - 1

M1 - 272

ER -